Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMe as an epigenetic treatment of depression with childhood trauma
2017-002097-38Phase 4Active
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive episode (MDE) comparing SAMe with Placebo (2 arms). Primary endpoint: Depression response (HAM-D). Started Apr 2018; status: active.
02
Drugs
S-adenosylmethionine
03
Conditions
major depressive episode (MDE)
Beyond the preview
Go deeper on 2017-002097-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002097-38.